Author

Eric S. Nisenbaum

Eli Lilly (United States)ORCID 0000-0002-0744-2712Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Jeff S. McDermottiD· 1 shared Jeffrey L. KrajewskiiD· 1 shared Reesha R. PateliD· 1 shared Shaun R. PateliD· 1 shared Theodore CumminsiD· 1 shared Xian Xuan Chi· 1 shared Xiaoming JiniD· 1 shared Xingjie PingiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Jeff S. McDermottORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preferential Pharmacological Inhibition of Nav1.6, but not Nav1.1, Abolishes Epileptiform Activity Induced by 4-AP in Mouse Cortical Slices

Reesha R. Patel, Xingjie Ping, Shaun R. Patel, Jeff S. McDermott, Jeffrey L. Krajewski, Xian Xuan Chi, Eric S. Nisenbaum, Xiaoming Jin, Theodore Cummins

This study investigates the effects of inhibiting specific voltage-gated sodium channel isoforms on epileptiform activity in mouse cortical slices, finding that Nav1.6 inhibition is more effective than Nav1.1 inhibition.

bioRxiv · May 29, 2020 · PreprintNeuroscience